Search

Author/Creator Davis Mark author non-byline.

1. Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT). Issue 1 (29th January 2013)

Authors:
MacDonald, Thomas M; Mackenzie, Isla S; Wei, Li; Hawkey, Christopher J; Ford, Ian
Other Names:
contributor.; Hallas Jesper author non-byline.; Webster John author non-byline.; Reid David author non-byline.; Ralston Stuart author non-byline.; Walters Matthew author non-byline.; Hobbs FD Richard author non-byline.; Ritchie Sir Lewis author non-byline.; Davis Mark author non-byline.; Perez-G...
Journal:
BMJ open
Issue:
Volume 3:Issue 1(2013)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. UKCGG Consensus Group guidelines for the management of patients with constitutional TP53 pathogenic variants. Issue 2 (22nd June 2020)

Authors:
Hanson, Helen; Brady, Angela F; Crawford, Gillian; Eeles, Rosalind A; Gibson, Sarah; Jorgensen, Mette; Izatt, Louise; Sohaib, Aslam; Tischkowitz, Marc; Evans, D Gareth
Other Names:
author non-byline.; Ahmed Muna author non-byline.; Angelini Paola author non-byline.; Brennan Paul author non-byline.; Brewer Carole author non-byline.; Cook Jackie author non-byline.; Davidson Rosemarie author non-byline.; Davis Mark author non-byline.; Souza Bianca de author non-byline.; Easto...
Journal:
Journal of medical genetics
Issue:
Volume 58:Issue 2(2021)
Page Start:
135
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search